Literature DB >> 4817154

Editorial: Management of neonatal jaundice.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4817154      PMCID: PMC1633493          DOI: 10.1136/bmj.1.5906.469

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  17 in total

1.  Phototherapy in rhesus haemolytic disease.

Authors:  M M Reid; E Marks; G McClure; J H Elwood
Journal:  Lancet       Date:  1972-04-22       Impact factor: 79.321

Review 2.  Phenobarbital in the perinatal period.

Authors:  J T Wilson
Journal:  Pediatrics       Date:  1969-03       Impact factor: 7.124

3.  The question of diarrhea and phototherapy.

Authors:  J L Washington; A W Brown; A L Starrett
Journal:  Pediatrics       Date:  1972-02       Impact factor: 7.124

4.  The combined effect of phototherapy and phenobarbital on serum bilirubin levels of premature infants.

Authors:  M G Blackburn; M M Orzalesi; P Pigram
Journal:  Pediatrics       Date:  1972-01       Impact factor: 7.124

5.  Kernicterus in small sick premature infants receiving phototherapy.

Authors:  W J Keenan; P H Perlstein; I J Light; J M Sutherland
Journal:  Pediatrics       Date:  1972-05       Impact factor: 7.124

6.  The "bronze" baby syndrome: a complication of phototherapy.

Authors:  A E Kopelman; R S Brown; G B Odell
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

7.  Fluoride as a nutrient: American Academy of Pediatrics Committee on Nutrition.

Authors: 
Journal:  Pediatrics       Date:  1972-03       Impact factor: 7.124

8.  Phototherapy of jaundice in newborn infant. I. ABO blood group incompatibility.

Authors:  T R Sisson; N Kendall; S C Glauser; S Knutson; E Bunyaviroch
Journal:  J Pediatr       Date:  1971-12       Impact factor: 4.406

9.  Phenobarbitone in rhesus haemolytic disease. A controlled trial.

Authors:  G P McMullin; M F Hayes; S C Arora
Journal:  Lancet       Date:  1970-11-07       Impact factor: 79.321

10.  Controlled clinical trial of phenobarbital and-or light in reducing neonatal hyperbilirubinemia in a predominantly Negro population.

Authors:  O S Valdes; H M Maurer; C N Shumway; D A Draper; A A Hossaini
Journal:  J Pediatr       Date:  1971-12       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.